Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03865316 · ClinicalTrials.gov registry record · NA

Comparison of Depth of Sedation Performance Between SedLine and Comparator Device During General Anesthesia

A NA study of Anesthesia, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT03865316: Completed NA study of Anesthesia, sponsored by Masimo Corporation.

NCT03865316 is a NA study of Anesthesia that has completed, run by Masimo Corporation. The registered enrollment target is 108 participants, below the 109,408-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03865316, a NA study of Anesthesia, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

The primary objective is to compare the performance of Masimo's SedLine and the comparator's device systems during surgery. Relative accuracy of the individual depth of sedation indices will be compared.

Primary Outcome

The correlation was computed using 1 min average values between the PSi and the comparator's sedation index.

Conditions Studied

Interventions

  • DEVICE SedLine Vs Comparator Test Group

Study Locations (1)

California

  • UC Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2019-01-25
Est. Completion 2021-03-11
Phase NA
Masimo Corporation

96 total trials

What the finished NCT03865316 record still lists

NCT03865316 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 109,408-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which SedLine Vs Comparator Test Group is the first listed.

NCT03865316 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03865316 about?

NCT03865316 is a clinical study titled "Comparison of Depth of Sedation Performance Between SedLine and Comparator Device During General Anesthesia". The primary objective is to compare the performance of Masimo's SedLine and the comparator's device systems during surgery. Relative accuracy of the individual depth of sedation indices will be compared.

What is the current status of trial NCT03865316?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2019-01-25. Estimated completion is 2021-03-11.

What conditions does trial NCT03865316 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT03865316?

The interventions under investigation include: SedLine Vs Comparator Test Group (DEVICE).

Who is sponsoring clinical trial NCT03865316?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03865316 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03865316's enrollment target sits among peer trials

108 15th of 57 higher than 43 of 57 other Anesthesia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03865316, the US trial registry maintained by the National Library of Medicine. NCT03865316 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.